Activase® Alteplase 50 mg Injection 29 Million IU

Features

• Activase® (alteplase) is indicated for the treatment of acute ischemic stroke (AIS)
• Activase® is indicated for use in acute myocardial infarction (AMI) for the reduction of mortality and reduction of the incidence of heart failure
• Activase® is indicated for the lysis of acute massive pulmonary embolism (PE)
• Using a large bore needle (e.g., 18 gauge) and a syringe, reconstitute by adding the contents of the accompanying 50 mL vial of SWFI to the 50 mg vial of Activase, directing the SWFI stream into the lyophilized cake

More Information

• MSDS